[HTML][HTML] Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational …
Q Shao, M Xiong, J Li, H Hu, H Su, Y Xu - Chemical Science, 2023 - pubs.rsc.org
Papain-like protease (PLpro) is a promising therapeutic target against SARS-CoV-2, but its
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
[HTML][HTML] Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational …
Q Shao, M Xiong, J Li, H Hu, H Su, Y Xu - Chemical Science, 2023 - ncbi.nlm.nih.gov
Papain-like protease (PL pro) is a promising therapeutic target against SARS-CoV-2, but its
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches
Q Shao, M Xiong, J Li, H Hu, H Su… - Chemical …, 2023 - pubmed.ncbi.nlm.nih.gov
Papain-like protease (PL pro) is a promising therapeutic target against SARS-CoV-2, but its
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches.
Q Shao, M Xiong, J Li, H Hu, H Su, Y Xu - Chemical Science, 2023 - europepmc.org
Papain-like protease (PLpro) is a promising therapeutic target against SARS-CoV-2, but its
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
[PDF][PDF] Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational …
Q Shao, M Xiong, J Li, H Hu, H Sua, Y Xu - 2023 - pdfs.semanticscholar.org
Papain-like protease (PLpro) is a promising therapeutic target against SARS-CoV-2, but its
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
[引用][C] Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational …
Q Shao, M Xiong, J Li, H Hu, H Sua, Y Xu - 2023 - europepmc.org
Papain-like protease (PLpro) is a promising therapeutic target against SARS-CoV-2, but its
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …
restricted S1/S2 subsites pose an obstacle in developing active site-directed inhibitors. We …